共 42 条
[1]
D’Souza A(2008)Granulocyte colony stimulating factor administration: adverse events Transfus Med Rev 22 280-290
[2]
Jaiyesimi I(2004)Granulocyte colony-stimulating factor induces disease flare in patients with antineutrophil cytoplasmic antibody-associated vasculitis J Rheumatol 31 1655-1658
[3]
Trainor L(1995)Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for felty’s syndrome Am J Med 98 589-590
[4]
Venuturumili P(1994)Cutaneous vasculitis associated with granulocyte colony-stimulating factor J Am Acad Derm 32 213-215
[5]
Iking-Konert C(1999)Leukocytoclastic vasculitis as a complication of granulocyte colony-stimulating factor (G-CSF) – a case study Ann Hematol 78 79-81
[6]
Ostendorf B(1992)The sweet syndrome during therapy with granulocyte colony-stimulating factor Ann Int Med 116 996-998
[7]
Foede M(2004)Aortite après injections de G-CSF Rev Med Interne 25 225-229
[8]
Fischer-Betz R(2009)Abdominal aortitis after use of granulocyte colony stimulating factor Clin Drug Investig 29 821-825
[9]
Jung G(2003)G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases Blood 102 734-739
[10]
Haensch MG(undefined)undefined undefined undefined undefined-undefined